Evidence map›Paper›PMID 35195510›Full record

ArticleMicrobial genomics2022

Unveiling the genomic potential of

Zaki Saati-Santamaría, Nelly Selem-Mojica, Ezequiel Peral-Aranega, Raúl Rivas, Paula García-Fraile

Open access · goldAbstract read
In one paragraph

Article in Microbial genomics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Microbial genomics · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zaki Saati-SantamaríaMicrobiology and Genetics Department, University of Salamanca, 37007 Salamanca, Spain.
Nelly Selem-MojicaCentro de Ciencias Matemáticas UNAM, 58089, Morelia, Michoacán, Mexico.
Ezequiel Peral-AranegaMicrobiology and Genetics Department, University of Salamanca, 37007 Salamanca, Spain.
Raúl RivasMicrobiology and Genetics Department, University of Salamanca, 37007 Salamanca, Spain.
Paula García-FraileMicrobiology and Genetics Department, University of Salamanca, 37007 Salamanca, Spain.
Universidad de Salamanca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbes host a huge variety of biosynthetic gene clusters that produce an immeasurable array of secondary metabolites with many different biological activities such as antimicrobial, anticarcinogenic and antiviral. Despite the complex task of isolating and characterizing novel natural products, microbial genomic strategies can be useful for carrying out these types of studies. However, although genomic-based research on secondary metabolism is on the increase, there is still a lack of reports focusing specifically on the genus

Indexed as

Biological ProductsPseudomonasGenomicsMultigene FamilyPhylogenyBiological ProductsBGCsBiG-SCAPE / CORASONcomparative genomicsEvoMiningpan-genomesecondary metabolites

Identifiers

PMID35195510
PMCPMC8942027
OpenAlexW4213430595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.